PTPN22 and neoplasm: By contrast, tumor-targeting/homing peptides (e.g., RGD, angiopep-2, Lyp-1, and GE11 peptides) can be recognized by specific receptors in the tumor cells or the tumor microenvironment, being able to differentiate tumor and normal cells [145].